The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Landmark Supreme Court Decision Supports States’ Rights to Regulate Pharmacy Benefit Managers

Landmark Supreme Court Decision Supports States’ Rights to Regulate Pharmacy Benefit Managers

December 16, 2020 • By Keri Losavio

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Photo: Insta_Photos; Erik Cox Photography/Shutterstock.com

On Dec. 10, the Supreme Court of the United States of America (SCOTUS) issued a landmark decision in Rutledge, Attorney General of Arkansas, v. Pharmaceutical Care Management Association. In an 8–0 decision, the justices agreed that states have the right to impose regulations on pharmacy benefit managers (PBMs), companies that manage prescription drug benefits on behalf of health insurers, Medicare Part D drug plans, large employers and other payers. Justice Amy Coney Barrett took no part in the consideration or decision of this case.

You Might Also Like
  • Kentucky Launches Probe into Drug Overcharges by Pharmacy Benefit Managers
  • Rheumatologists Air Frustrations with Pharmacy Benefit Managers at Annual Meeting
  • U.S. Probes Contracts Between Drugmakers, Pharmacy Benefit Managers
Explore This Issue
January 2021
Also By This Author
  • New Membership & Nominations Chair Dr. Hazel Breland Outlines Goals for ARP Membership Growth

The ACR and the Alliance for Transparent and Affordable Prescriptions (ATAP), a coalition of patient and provider groups, have long argued that too few restrictions have been placed on PBM transparency and requirements for PBMs to pass negotiated savings on to payers and patients are needed. This decision from SCOTUS sets the stage for states to impose further regulations to ensure patients and providers have necessary protections and the profit motives of PBMs are clear to all.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The ACR has played an active role in these issues in Arkansas and other states as the states crafted new regulations involving PBMs. The ACR and its partners in the ATAP coalition also filed an amicus brief in the Rutledge case arguing in part that PBMs are engaged in abusive practices with serious practical and policy consequences, including upward pressure on prescription drug pricing.

“The Supreme Court is now amplifying the light we are shining on the previously hidden profit motives of the PBM industry,” said Angus Worthing, MD, a practicing rheumatologist with Arthritis & Rheumatism Associates PC, Washington, D.C., a clinical assistant professor of medicine at Georgetown University, and past chair of the ACR’s Government Affairs Committee. “With this decision and other actions in Washington and various states, patients, physicians and policy makers now have the power to effect meaningful change.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Filed Under: American College of Rheumatology, Practice Management Tagged With: Alliance for Transparent & Affordable Prescriptions (ATAP), pharmacy benefit managers (PBMs), U.S. Supreme CourtIssue: January 2021

You Might Also Like:
  • Kentucky Launches Probe into Drug Overcharges by Pharmacy Benefit Managers
  • Rheumatologists Air Frustrations with Pharmacy Benefit Managers at Annual Meeting
  • U.S. Probes Contracts Between Drugmakers, Pharmacy Benefit Managers
  • Supreme Court Decision on Gene Patents Good News for Clinicians, Researchers

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)